SCHEMBL6945807

SCHEMBL6945807

COCCCN1CCN(CC[O])CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
SLC29A1 Q99808 2/20 0.37
DRD2 P14416 1/20 0.36
HSD11B1 P28845 1/20 0.36
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ABCC4 O15439 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2A P28223 1/20 0.35
MAPK1 P28482 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8880908 0.91 ALDH1A1 (0.38) ALDH1A1KDM4ESLC29A1DRD2HSD11B1
SCHEMBL6043320 0.89 ALDH1A1 (0.37) ALDH1A1KDM4ESLC29A1DRD2HSD11B1
SCHEMBL10924619 0.89 ALDH1A1 (0.39) ALDH1A1KDM4ESLC29A1DRD2CYP2D6
SCHEMBL11575418 0.89
SCHEMBL6042277 0.87 DRD2 (0.40) ALDH1A1KDM4ESLC29A1DRD2HSD11B1
SCHEMBL3318840 0.86 HSD11B1 (0.45) ALDH1A1KDM4ESLC29A1DRD2HSD11B1
SCHEMBL10930283 0.84 HSD11B1 (0.42) ALDH1A1KDM4ESLC29A1HSD11B1MAPK1
SCHEMBL3451890 0.83 HSD11B1 (0.42) ALDH1A1KDM4ESLC29A1DRD2HSD11B1
SCHEMBL25960101 0.83 ALDH1A1 (0.35) ALDH1A1KDM4ESLC29A1DRD2HSD11B1
SCHEMBL84799 0.82 HRH3 (0.46) ALDH1A1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003103652-A1 METHODS OF TREATING ALZHEIMER’S DISEASE USING AROMATICALLY SUBSTITUTED ω-AMINO-ALKANOIC ACID AMIDES AND ALKANOIC ACID DIAMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed
US-5641778-A EXHIBIT RENIN-INHIBITING PROPERTIES AND CAN BE USED AS ANTIHYPERTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1997-06-24 US disclosed
EP-0716077-A1 Aromatically substituted omega amino alcanoic acid amides and alcanoic diamides and their use as renine inhibitors CIBA-GEIGY AG (CH) 1996-06-12 EP disclosed